Cough management program for lung scarring
Part of Lungs & breathing clinical trials.
This trial is testing a telehealth program (using phone calls or video meetings) to help people with interstitial lung disease manage chronic cough. If you join, you'll get guidance and support to improve your cough symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with interstitial lung disease (a condition that causes scarring of the lungs).
- You have had a persistent cough lasting more than 8 weeks.
- You do not cough up more than about 2 tablespoons of phlegm or mucus regularly.
- You have not had a recent flare-up or respiratory infection in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two cough-relief medicines, gabapentin and benzonatate, against usual care in people with interstitial lung disease (lung scarring) who have had a chronic cough for at least 8 weeks. It aims to see which option works better and is safer.
This trial tests a 4-week program that teaches breathing-focused techniques (based on acceptance and commitment therapy) to help people with chronic cough. The program is done over video with a facilitator, and the study will see if it is practical and helpful for managing cough symptoms.
This Phase 2 study tests whether two different doses of duloxetine and amitriptyline can reduce coughing caused by interstitial lung disease (ILD). If you have had a long-lasting ILD-related cough despite stable ILD treatment, this trial may help find a better way to control your cough.
This trial tests a behavioral therapy for people whose chronic cough (lasting more than 8 weeks) hasn't improved with usual treatments like asthma or reflux medicine. You may join if your cough is triggered by things like talking, laughing, cold air, or irritants, and you have throat symptoms like irritation or hoarseness.
This study tests a non-medication cough-control program for people who have lung scarring (interstitial lung disease) and a cough lasting more than 8 weeks. It may help you control coughing better without adding new medicines.
This study uses analysis of mucus (sputum) to guide treatment with the goal of reducing long-lasting cough in adults with interstitial lung disease (ILD). You may be asked to provide sputum samples and may receive treatment decisions based on those results.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.